| SS.SHR-(D2Rat61-D2Mco18)/Mco |
timed urine volume |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine output |
male |
140.0 days
| 6 |
22.3 |
ml/d |
5.1 |
12.49 |
urine volume measurement method |
0.0 |
|
|
|
|
68009 |
834 |
| SS/NEisSlc |
timed urine volume |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
urine output |
male |
126.0 days
| 8 |
53.6 |
ml/d |
7.1 |
20.08 |
urine volume measurement method |
0.0 |
|
|
|
|
102335 |
2684 |
| LH/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112.0 days
| 11 |
11.6 |
ml/d |
0.4 |
1.33 |
urine volume measurement method |
0.0 |
|
|
|
|
102732 |
2721 |
| Slc:W |
timed urine volume |
controlled ipragliflozin content diet (0.008 %) (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
urine output |
male |
105.0 days
| |
26.9 |
ml/d |
2.2 |
|
urine volume measurement method |
0.0 |
|
|
|
n=4-6 |
102923 |
2781 |
| LL/Mav |
timed urine volume |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56.0 days
| 18 |
8.9 |
ml/d |
0.3 |
1.27 |
urine volume measurement method |
0.0 |
|
|
|
|
102707 |
2721 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
84.0 days
| 6 |
13.4 |
ml/d |
2.6 |
6.37 |
urine volume measurement method |
0.0 |
|
|
|
|
99841 |
2319 |
| F344-Hsd11b2em1Jmul+/+ |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168.0 days
| 4 |
42.04 |
ml/d |
1.9 |
3.8 |
urine volume measurement method |
0.0 |
|
|
|
|
105011 |
3008 |
| F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
161.0 days
| 5 |
16.15 |
ml/d |
0.78 |
1.74 |
urine volume measurement method |
0.0 |
|
|
|
|
105010 |
3008 |
| MNS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63.0 days
| 10 |
14.2 |
ml/d |
1.66 |
5.26 |
urine volume measurement method |
0.0 |
|
|
|
|
104168 |
2927 |
| SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 21 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
84.0 days
| 10 |
71.34 |
ml/d |
2.26 |
7.15 |
urine volume measurement method |
0.0 |
|
|
|
|
105771 |
3022 |
| SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (8 %) (for 21 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
84.0 days
| 10 |
78.3 |
ml/d |
4.96 |
15.68 |
urine volume measurement method |
0.0 |
|
|
|
|
105770 |
3022 |
| BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
89.0 days-92.0 days |
25 |
35.0 |
ml/d |
2.0 |
10.0 |
urine volume measurement method |
0.0 |
|
|
|
|
69451 |
151 |
| SS/NEisSlc |
timed urine volume |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
urine output |
male |
126.0 days
| 8 |
83.3 |
ml/d |
7.9 |
22.34 |
urine volume measurement method |
0.0 |
|
|
|
|
102336 |
2684 |
| WKY |
timed urine volume |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
53.91 |
ml/d |
7.67 |
24.25 |
urine volume measurement method |
0.0 |
|
|
|
|
99124 |
2219 |
| LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56.0 days
| 14 |
10.6 |
ml/d |
0.3 |
1.12 |
urine volume measurement method |
0.0 |
|
|
|
|
102709 |
2721 |
| LL/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
urine output |
male |
49.0 days-56.0 days |
13 |
8.4 |
ml/d |
0.3 |
1.08 |
urine volume measurement method |
0.0 |
|
|
|
|
102647 |
2703 |
| WKY |
timed urine volume |
vehicle control condition (1 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
17.1 |
ml/d |
1.57 |
4.96 |
urine volume measurement method |
0.0 |
|
|
|
|
99119 |
2219 |
| WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
10.6 |
ml/d |
2.2 |
5.82 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100362 |
2460 |
| LL/Mav |
timed urine volume to body weight ratio |
right nephrectomy (between 9 and 10 days) then left kidney denervation then polyfructosan (1.25 %) (for 1.5 hours) and 0.9% sodium chloride solution (330 ul/kg/min) (for 1.5 hours) and bovine serum albumin (1 %) (for 1.5 hours) then abdominal aorta constriction and celiac artery and superior mesenteric artery constriction |
Miao CY, et al., J Hypertens. 2005 Jun;23(6):1225-31. |
urine output |
male |
112.0 days
| 9 |
34.0 |
ul/min/g |
8.6 |
25.8 |
urine volume measurement method |
0.0 |
|
|
|
|
104612 |
2970 |
| LH/Mav |
timed urine volume to body weight ratio |
right nephrectomy (between 9 and 10 days) then left kidney denervation then polyfructosan (1.25 %) (for 1.5 hours) and 0.9% sodium chloride solution (330 ul/kg/min) (for 1.5 hours) and bovine serum albumin (1 %) (for 1.5 hours) then abdominal aorta constriction and celiac artery and superior mesenteric artery constriction |
Miao CY, et al., J Hypertens. 2005 Jun;23(6):1225-31. |
urine output |
male |
112.0 days
| 9 |
20.5 |
ul/min/g |
1.9 |
5.7 |
urine volume measurement method |
0.0 |
|
|
|
|
104611 |
2970 |
| F344-Hsd11b2em1Jmul+/+ |
timed urine volume |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
161.0 days
| 4 |
4.6 |
ml/d |
0.18 |
0.36 |
urine volume measurement method |
0.0 |
|
|
|
|
105009 |
3008 |
| F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168.0 days
| 5 |
69.15 |
ml/d |
2.06 |
4.61 |
urine volume measurement method |
0.0 |
|
|
|
|
105012 |
3008 |
| MHS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
270.0 days
| 10 |
15.2 |
ml/d |
1.23 |
3.9 |
urine volume measurement method |
0.0 |
|
|
|
|
104172 |
2927 |
| SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (0.4 %) (for 63 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
63.0 days
| 10 |
7.93 |
ml/d |
1.49 |
4.71 |
urine volume measurement method |
0.0 |
|
|
|
|
105764 |
3022 |
| SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 7 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
70.0 days
| 10 |
65.69 |
ml/d |
5.1 |
16.13 |
urine volume measurement method |
0.0 |
|
|
|
|
105767 |
3022 |
| SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (8 %) (for 14 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
77.0 days
| 10 |
65.69 |
ml/d |
5.1 |
16.13 |
urine volume measurement method |
0.0 |
|
|
|
|
105768 |
3022 |
| SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
91.0 days
| 10 |
72.03 |
ml/d |
2.71 |
8.57 |
urine volume measurement method |
0.0 |
|
|
|
|
105772 |
3022 |
| SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 14 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
77.0 days
| 10 |
68.62 |
ml/d |
5.94 |
18.78 |
urine volume measurement method |
0.0 |
|
|
|
|
105769 |
3022 |
| SS/NEisSlc |
timed urine volume to body weight ratio |
controlled E4177 content drinking water (1.66 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
urine output |
not specified |
547.0 days
| 10 |
0.01 |
ul/min/g |
0.0 |
0.0 |
urine volume measurement method |
0.0 |
|
|
|
|
107432 |
2339 |
| SHR/NHsdMco |
timed urine volume |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine output |
male |
140.0 days
| 6 |
14.2 |
ml/d |
3.4 |
8.33 |
urine volume measurement method |
0.0 |
|
|
|
|
68008 |
834 |
| SS/JrTol |
timed urine volume |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine output |
male |
140.0 days
| 6 |
14.2 |
ml/d |
1.86 |
4.56 |
urine volume measurement method |
0.0 |
|
|
|
|
68010 |
834 |
| Hsd:WI |
timed urine volume |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
6.8 |
ml/d |
0.61 |
1.5 |
urine volume measurement method |
0.0 |
|
|
|
|
75965 |
1544 |
| Hsd:WI |
timed urine volume |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
21.8 |
ml/d |
1.31 |
3.2 |
urine volume measurement method |
0.0 |
|
|
|
|
75966 |
1544 |
| FHH/EurMcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
56.0 days
| 6 |
47.0 |
ml/d |
3.4 |
8.33 |
urine volume measurement method |
0.0 |
|
|
|
|
99477 |
2318 |
| FHH-Nr4a1m1Mcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
168.0 days
| 6 |
24.0 |
ml/d |
2.1 |
5.14 |
urine volume measurement method |
0.0 |
|
|
|
|
99482 |
2318 |
| LL/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112.0 days
| 9 |
12.4 |
ml/d |
0.6 |
1.8 |
urine volume measurement method |
0.0 |
|
|
|
|
102730 |
2721 |
| GK/Slc |
timed urine volume |
controlled ipragliflozin content diet (0.008 %) (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
urine output |
male |
105.0 days
| |
29.3 |
ml/d |
3.6 |
|
urine volume measurement method |
0.0 |
|
|
|
n=4-6 |
102925 |
2781 |
| MNS |
timed urine volume |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine output |
male |
213.0 days
| 9 |
56.88 |
ml/d |
11.23 |
33.7 |
urine volume measurement method |
3600.0 |
|
|
|
|
104030 |
2886 |
| WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
10.6 |
ml/d |
2.2 |
5.82 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100376 |
2460 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
252.0 days
| 6 |
13.8 |
ml/d |
3.3 |
8.08 |
urine volume measurement method |
0.0 |
|
|
|
|
99845 |
2319 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
252.0 days
| 7 |
19.5 |
ml/d |
4.6 |
12.17 |
urine volume measurement method |
0.0 |
|
|
|
|
99844 |
2319 |
| WKY |
timed urine volume |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
140.19 |
ml/d |
10.38 |
32.82 |
urine volume measurement method |
0.0 |
|
|
|
|
99120 |
2219 |
| WKY |
timed urine volume |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
13.9 |
ml/d |
1.6 |
4.23 |
urine volume measurement method |
0.0 |
lad occlusion sham |
196 |
days |
|
100360 |
2460 |
| WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100361 |
2460 |
| F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168.0 days
| 5 |
3.8 |
ml/d |
0.3 |
0.67 |
urine volume measurement method |
0.0 |
|
|
|
|
105014 |
3008 |
| MNS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
270.0 days
| 10 |
14.4 |
ml/d |
1.56 |
4.93 |
urine volume measurement method |
0.0 |
|
|
|
|
104171 |
2927 |
| WI-Mc4rm1Hubr |
timed urine volume |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
urine output |
male |
70.0 days-140.0 days |
8 |
25.0 |
ml/d |
2.0 |
5.66 |
urine volume measurement method |
0.0 |
|
|
|
|
105521 |
3017 |
| SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (0.4 %) (for 63 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
63.0 days
| 10 |
5.26 |
ml/d |
0.51 |
1.61 |
urine volume measurement method |
0.0 |
|
|
|
|
105765 |
3022 |
| BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92.0 days-94.0 days |
25 |
9.86 |
ml/d |
0.4 |
2.0 |
urine volume measurement method |
0.0 |
|
|
|
needs ml/d default |
69464 |
151 |
| SS/JrHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92.0 days-94.0 days |
15 |
7.8 |
ml/d |
0.6 |
2.32 |
urine volume measurement method |
0.0 |
|
|
|
needs ml/d default |
69465 |
151 |
| SS/JrHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
89.0 days-92.0 days |
17 |
30.0 |
ml/d |
2.2 |
9.07 |
urine volume measurement method |
0.0 |
|
|
|
|
69452 |
151 |
| Hsd:WI |
timed urine volume |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
10.0 |
ml/d |
0.78 |
1.9 |
urine volume measurement method |
0.0 |
|
|
|
|
75967 |
1544 |
| SR/NEisSlc |
timed urine volume |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
urine output |
male |
126.0 days
| 8 |
30.4 |
ml/d |
6.8 |
19.23 |
urine volume measurement method |
0.0 |
|
|
|
|
102334 |
2684 |
| FHH/EurMcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
168.0 days
| 6 |
24.0 |
ml/d |
3.7 |
9.06 |
urine volume measurement method |
0.0 |
|
|
|
|
99481 |
2318 |
| FHH-Nr4a1m1Mcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
112.0 days
| 6 |
31.0 |
ml/d |
3.7 |
9.06 |
urine volume measurement method |
0.0 |
|
|
|
|
99480 |
2318 |
| LL/Mav |
timed urine volume |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112.0 days
| 18 |
10.8 |
ml/d |
0.3 |
1.27 |
urine volume measurement method |
0.0 |
|
|
|
|
102731 |
2721 |
| Slc:W |
timed urine volume |
vehicle control condition (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
urine output |
male |
105.0 days
| |
11.2 |
ml/d |
0.5 |
|
urine volume measurement method |
0.0 |
|
|
|
n=4-6 |
102922 |
2781 |
| WKY |
timed urine volume |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
13.9 |
ml/d |
1.6 |
4.23 |
urine volume measurement method |
0.0 |
lad occlusion sham |
196 |
days |
|
100374 |
2460 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
84.0 days
| 7 |
14.7 |
ml/d |
2.6 |
6.88 |
urine volume measurement method |
0.0 |
|
|
|
|
99840 |
2319 |
| Crl:WI |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63.0 days
| 10 |
15.6 |
ml/d |
2.25 |
7.13 |
urine volume measurement method |
0.0 |
|
|
|
|
104173 |
2927 |
| SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (8 %) (for 7 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
70.0 days
| 10 |
74.41 |
ml/d |
4.44 |
14.04 |
urine volume measurement method |
0.0 |
|
|
|
|
105766 |
3022 |
| SS/NEisSlc |
timed urine volume to body weight ratio |
controlled cilazapril content drinking water (0.16 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
urine output |
not specified |
547.0 days
| 10 |
0.02 |
ul/min/g |
0.0 |
0.0 |
urine volume measurement method |
0.0 |
|
|
|
|
107430 |
2339 |
| SS/NEisSlc |
timed urine volume to body weight ratio |
vehicle control condition (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
urine output |
not specified |
547.0 days
| 10 |
0.02 |
ul/min/g |
0.0 |
0.01 |
urine volume measurement method |
0.0 |
|
|
|
|
107429 |
2339 |
| Hsd:WI |
timed urine volume |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
9.2 |
ml/d |
0.69 |
1.7 |
urine volume measurement method |
0.0 |
|
|
|
|
75968 |
1544 |
| FHH-Nr4a1m1Mcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
56.0 days
| 6 |
37.0 |
ml/d |
2.1 |
5.14 |
urine volume measurement method |
0.0 |
|
|
|
|
99478 |
2318 |
| FHH/EurMcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
112.0 days
| 6 |
39.0 |
ml/d |
5.3 |
12.98 |
urine volume measurement method |
0.0 |
|
|
|
|
99479 |
2318 |
| LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112.0 days
| 14 |
11.9 |
ml/d |
0.5 |
1.87 |
urine volume measurement method |
0.0 |
|
|
|
|
102733 |
2721 |
| GK/Slc |
timed urine volume |
vehicle control condition (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
urine output |
male |
105.0 days
| |
9.6 |
ml/d |
0.7 |
|
urine volume measurement method |
0.0 |
|
|
|
n=4-6 |
102924 |
2781 |
| MHS |
timed urine volume |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine output |
male |
213.0 days
| 6 |
50.83 |
ml/d |
6.48 |
15.87 |
urine volume measurement method |
3600.0 |
|
|
|
|
104029 |
2886 |
| WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100375 |
2460 |
| LL/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56.0 days
| 9 |
9.1 |
ml/d |
0.4 |
1.2 |
urine volume measurement method |
0.0 |
|
|
|
|
102706 |
2721 |
| LH/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56.0 days
| 11 |
8.7 |
ml/d |
0.3 |
0.99 |
urine volume measurement method |
0.0 |
|
|
|
|
102708 |
2721 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
168.0 days
| 7 |
21.1 |
ml/d |
7.6 |
20.11 |
urine volume measurement method |
0.0 |
|
|
|
|
99842 |
2319 |
| SS-Nppbem2Mcwi-/- |
timed urine volume |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
urine output |
male |
168.0 days
| 6 |
14.0 |
ml/d |
6.7 |
16.41 |
urine volume measurement method |
0.0 |
|
|
|
|
99843 |
2319 |
| LH/Mav |
timed urine volume |
vehicle control condition |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
urine output |
male |
49.0 days-56.0 days |
8 |
8.7 |
ml/d |
0.6 |
1.7 |
urine volume measurement method |
0.0 |
|
|
|
|
102648 |
2703 |
| LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
urine output |
male |
49.0 days-56.0 days |
37 |
12.6 |
ml/d |
0.7 |
4.26 |
urine volume measurement method |
0.0 |
|
|
|
|
102649 |
2703 |
| WKY |
timed urine volume |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
62.68 |
ml/d |
15.67 |
49.55 |
urine volume measurement method |
0.0 |
|
|
|
|
99122 |
2219 |
| WKY |
timed urine volume |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
133.86 |
ml/d |
16.58 |
52.43 |
urine volume measurement method |
0.0 |
|
|
|
|
99121 |
2219 |
| WKY |
timed urine volume |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156.0 days
| 10 |
58.33 |
ml/d |
8.45 |
26.72 |
urine volume measurement method |
0.0 |
|
|
|
|
99123 |
2219 |
| LH/Mav |
timed urine volume to body weight ratio |
right nephrectomy (between 9 and 10 days) then left kidney denervation then aldosterone (66 ng/kg/min) (for 1.5 hours) and hydrocortisone (33 ng/kg/min) (for 1.5 hours) and norepinephrine (333 ng/kg/min) (for 1.5 hours) and argipressin (0.17 ng/kg/min) (for 1.5 hours) then abdominal aorta constriction and celiac artery and superior mesenteric artery constriction |
Miao CY, et al., J Hypertens. 2005 Jun;23(6):1225-31. |
urine output |
male |
112.0 days
| 8 |
9.3 |
ul/min/g |
1.4 |
3.96 |
urine volume measurement method |
0.0 |
|
|
|
|
104613 |
2970 |
| LL/Mav |
timed urine volume to body weight ratio |
right nephrectomy (between 9 and 10 days) then left kidney denervation then aldosterone (66 ng/kg/min) (for 1.5 hours) and hydrocortisone (33 ng/kg/min) (for 1.5 hours) and norepinephrine (333 ng/kg/min) (for 1.5 hours) and argipressin (0.17 ng/kg/min) (for 1.5 hours) then abdominal aorta constriction and celiac artery and superior mesenteric artery constriction |
Miao CY, et al., J Hypertens. 2005 Jun;23(6):1225-31. |
urine output |
male |
112.0 days
| 6 |
8.6 |
ul/min/g |
1.6 |
3.92 |
urine volume measurement method |
0.0 |
|
|
|
|
104614 |
2970 |
| F344-Hsd11b2em1Jmul+/+ |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168.0 days
| 5 |
3.4 |
ml/d |
0.2 |
0.45 |
urine volume measurement method |
0.0 |
|
|
|
|
105013 |
3008 |
| MHS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63.0 days
| 10 |
14.0 |
ml/d |
0.97 |
3.08 |
urine volume measurement method |
0.0 |
|
|
|
|
104169 |
2927 |
| Crl:WI |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63.0 days
| 10 |
14.8 |
ml/d |
1.35 |
4.27 |
urine volume measurement method |
0.0 |
|
|
|
|
104170 |
2927 |
| Crl:WI |
timed urine volume |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
urine output |
male |
70.0 days-140.0 days |
8 |
16.0 |
ml/d |
3.0 |
8.49 |
urine volume measurement method |
0.0 |
|
|
|
|
105520 |
3017 |
| SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
91.0 days
| 10 |
74.68 |
ml/d |
1.67 |
5.28 |
urine volume measurement method |
0.0 |
|
|
|
|
105773 |
3022 |
| SS/NEisSlc |
timed urine volume to body weight ratio |
controlled cilazapril content drinking water (0.94 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
urine output |
not specified |
547.0 days
| 10 |
0.02 |
ul/min/g |
0.0 |
0.01 |
urine volume measurement method |
0.0 |
|
|
|
|
107431 |
2339 |